Skip to main content Accessibility help
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Print publication year: 2013
  • Online publication date: November 2013

Chapter 28 - Linkage and candidate gene studies of obstructive sleep apnea

from Section 6 - Sleep-related breathing disorders


This chapter provides a brief description of the main animal models used in the study of sleep and cognition, which reveals their intercomplementary strength and scope. Two types of sleep deprivation are commonly carried out in rodents: total sleep deprivation (TSD) and rapid eye movement (REM) sleep deprivation (RSD). Memory consolidation during sleep could be a passive and unselective process due to a prolonged quiet period without any flow of information. The study of sleep-dependent cognitive processes is relatively recent in birds and few studies have so far included sleep deprivation. Sleep deprivation protocols include gentle handling, placing birds in a running wheel, the disc-over-water method, and constant light. Drosophila serves as a model system for the investigation of many cellular, developmental, and behavioral processes common to other species, including humans.

Related content

Powered by UNSILO


1. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med. 2002;165:1217–39.
2. McCarthy M. Genomics, type 2 diabetes, and obesity. N Engl J Med. 2010;363:2339–50.
3. Sassani A, Findley L, Kryger M, et al. Reducing motor-vehicle collisions, costs, and fatalities by treating obstructive sleep apnea syndrome. Sleep. 2004;27:453–58.
4. Tasali E, Ip M. Obstructive sleep apnea and metabolic syndrome: alterations in glucose metabolism and inflammation. Proc Am Thorac Soc. 2008;5:207–17.
5. Pack A, Gislason T. Obstructive sleep apnea and cardiovascular disease: a perspective and future directions. Prog Cardiovasc Dis. 2009;51:434–51.
6. Yaffe K, Laffan A, Harrison S, et al. Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. J Am Med Assoc. 2011;306:613–19.
7. Nieto F, Peppard P, Young T, et al. Sleep-disordered breathing and cancer mortality: results from the Wisconsin Sleep Cohort Study. Am J Respir Crit Care Med. 2012;186:190–94.
8. Kaparianos A, Sampsonas F, Karkoulias K, et al. Obstructive sleep apnoea syndrome and genes. Neth J Med. 2006;64:280–89.
9. Redline S, Tishler PV, Tosteson TD, et al. The familial aggregation of obstructive sleep apnea. Am J Respir Crit Care Med. 1995;151:682–87.
10. Guilleminault C, Partinen M, Hollman K, et al. Familial aggregates in obstructive sleep apnea syndrome. Chest. 1995;107:1545–51.
11. Mathur R, Douglas N. Family studies in patients with the sleep apnea–hypopnea syndrome. Ann Intern Med. 1995;122:174–78.
12. Douglas N, Luke M, Mathur R. Is the sleep apnoea/hypopnoea syndrome inherited? Thorax. 1993;48:719–21.
13. Pillar G, Lavie P. Assessment of the role of inheritance in sleep apnea syndrome. Am J Respir Crit Care Med. 1995;151:688–91.
14. Gislason T, Johannsson JH, Haraldsson A, et al. Familial predisposition and cosegregation analysis of adult obstructive sleep apnea and the sudden infant death syndrome. Am J Respir Crit Care Med. 2002;166:833–38.
15. Palmer LJ, Redline S. Genomic approaches to understanding obstructive sleep apnea. Respir Physiol Neurobiol. 2003;135:187–205.
16. Ancoli-Israel S, Klauber M, Stepnowsky C, et al. Sleep-disordered breathing in African-American elderly. Am J Respir Crit Care Med. 1995;152:1946–49.
17. Loredo J, Soler X, Bardwell W, et al. Sleep health in U.S. Hispanic population. Sleep. 2010;33:962–67.
18. Lee R, Vasudavan S, Hui D, et al. Differences in craniofacial structures and obesity in Caucasian and Chinese patients with obstructive sleep apnea. Sleep. 2010;33:1075–80.
19. Liu F, van der Lijn F, Schurmann C, et al. A genome-wide association study identifies five loci influencing facial morphology in Europeans. PLoS Genet. 2012;8:e1002932.
20. Altmüller J, Palmer L, Fischer G, et al. Genome-wide scans of complex human diseases: true linkage is hard to find. Am J Hum Genet. 2001;69:936–50.
21. Weeks D, Lathrop G. Polygenic disease: methods for mapping complex disease traits. Trends Genet. 1995;11:513–19.
22. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet. 1995;11:241–47.
23. Lander E, Schork N. Genetic dissection of complex traits. Science. 1994;265:2037–48.
24. Silverman EK, Palmer LJ. Case-control association studies for the genetics of complex respiratory diseases. Am J Respir Cell Mol Biol. 2000;22:645–48.
25. Cardon LR, Bell JI. Association study designs for complex diseases. Nat Rev Genet. 2001;2:91–99.
26. Botstein D, Risch N. Discovering genotypes underlying human phenotypes: past successes for Mendelian disease, future approaches for complex disease. Nat Genet. 2003;33:228–37.
27. Stranger B, Stahl E, Raj T. Progress and promise of genome-wide association studies for human complex trait genetics. Genetics. 2011;187:367–83.
28. Cardon LR, Palmer LJ. Population stratification and spurious allelic association. Lancet. 2003;361:598–604.
29. Edwards T, Gao X. Methods for detecting and correcting for population stratification. Curr Protoc Hum Genet. 2012;22:1–14.
30. Wildenauer DB, Hallmayer J, Schwab SG. Genetics of complex psychiatric disorders: scientific foundations. Israel J Psychiat. 2002;39:232–39.
31. McGinnis R, Shifman S, Darvasi A. Power and efficiency of the TDT and case-control design for association scans. Behav Genet. 2002;32:135–44.
32. Zhu M, Zhao S. Candidate gene identification approach: progress and challenges. Int J Biol Sci 2007;3:420–27.
33. Crawford DC, Nickerson DA. Definition and clinical importance of haplotypes. Annu Rev Med. 2005;56:303–20.
34. The International HapMap Consortium. A second generation human haplotype map of over 3.1 million SNPs. Nature. 2007;449:851–61.
35. Daly A, Day C. Candidate gene case-control association studies: advantages and potential pitfalls. Br J Clin Pharmacol 2001;52:489–99.
36. Zondervan KT, Cardon LR. The complex interplay among factors that influence allelic association. Nat Rev Genet. 2004;5:89–100.
37. Tabor HK, Risch NJ, Myers RM. Opinion: Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet. 2002;3:391–97.
38. Schaid DJ. Disease-marker association. In: Elston RC, Olson JM, Palmer LJ (eds), Biostatistical Genetics and Genetic Epidemiology. Chichester: John Wiley & Sons; 2002.
39. Klein R, Zeiss C, Chew E, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308:385–89.
40. Ragoussis J. Genotyping technologies for genetic research. Annu Rev Genomics Hum Genet. 2009;10:117–33.
41. Winkelmann J. Genetics of restless legs syndrome. Curr Neurol Neurosci Rep. 2008;8:211–16.
42. Tafti M, Dauvilliers Y, Overeem S. Narcolepsy and familial advanced sleep-phase syndrome: molecular genetics of sleep disorders. Curr Opin Genet Dev. 2007;17:222–27.
43. Sleiman P, Hakonarson H. Genetic underpinnings of obstructive sleep apnea: are we making progress? Sleep. 2011;34:1449–52.
44. Larkin E, Patel S, Elston R, et al. Using linkage analysis to identify quantitative trait loci for sleep apnea in relationship to body mass index. Ann Hum Genet. 2008;72:762–73.
45. Palmer LJ, Buxbaum SG, Larkin EK, et al. A whole-genome scan for obstructive sleep apnea and obesity. Am J Hum Genet. 2003;72:340–50.
46. Palmer LJ, Buxbaum SG, Larkin EK, et al. Whole genome scan for obstructive sleep apnea and obesity in African-American families. Am J Respir Crit Care Med. 2004;169:1314–21.
47. Buxbaum S, Elston R, Tishler P, et al. Genetics of the apnea hypopnea index in Caucasians and African Americans: I. Segregation analysis. Genet Epidemiol. 2002;22:243–53.
48. Patel SR. Shared genetic risk factors for obstructive sleep apnea and obesity. J Appl Physiol. 2005;99:1600–06.
49. Relf B, Larkin E, DeTorres C, et al. Genome-wide linkage of obstructive sleep apnoea and high-density lipoprotein cholesterol in a Filipino family: bivariate linkage analysis of obstructive sleep apnoea. J Sleep Res. 2010;19:349–57.
50. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 1996;273:1516–17.
51. Risch N. Searching for genetic determinants in the new millennium. Nature. 2000;405:847–56.
52. Varvarigou V, Dahabreh I, Malhotra A, et al. A review of genetic association studies of obstructive sleep apnea: field synopsis and meta-analysis. Sleep. 2011;34:1461–68.
53. Fedson AC. The genetic epidemiology of obstructive sleep apnea and its inter-relationship with cardiovascular and metabolic co-morbidities. Thesis (PhD), University of Western Australia; 2011.
54. Khalyfa A, Serpero L, Kheirandish-Gozal L, et al. TNF-α gene polymorphisms and excessive daytime sleepiness in pediatric obstructive sleep apnea. J Pediatr. 2011;158:81–86.
55. Silverman E. Network medicine approaches to the genetics of complex diseases. Discov Med. 2012;14:143–52.
56. Gulcher JR, Kong A, Stefansson K. The role of linkage studies for common diseases. Curr Opin Genet Dev. 2001;11:264–67.
57. Risch N, Zhang H. Extreme discordant sib pairs for mapping quantitative trait loci in humans. Science. 1995;268:1584–89.
58. Redline S, Palmer L, Elston R. Genetics of obstructive sleep apnea and related phenotypes. Am J Respir Cell Mol Biol. 2004;31:S35.
59. Larkin E, Patel S, Goodloe R, et al. A candidate gene study of obstructive sleep apnea in European Americans and African Americans. Am J Respir Crit Care Med 2010;182:947–53.
60. Gislason T, Pack A, Helgadottir H, et al. The CRP and GDNF genes do not contribute to apnea–hypopnea index or risk of obstructive sleep apnea. Am J Respir Crit Care Med. 2011;184:143–44.
61. Riha R, McNicholas W. The genetic and cardiovascular aspects of obstructive sleep apnoea/hypopnoea syndrome. Eur Respir J. 2009;2:233–36.
62. Patel S, Goodloe R, De G, et al. Association of genetic loci with sleep apnea in European Americans and African-Americans: the Candidate Gene Association Resource (CARe). PLoS One 2012;7:e48836.
63. Keating B, Tischfield S, Murray S, et al. Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies. PLoS ONE. 2008;3:e3583.
64. Loos RJF. The genetic determinants of common obesity-susceptibility. In: Symonds ME (ed.), Adipose Tissue Biology. New York, NY: Springer; 2012:317–78.
65. Speliotes E, Willer C, Berndt S, et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet. 2010;42:937–48.
66. Schwab RJ, Pasirstein M, Kaplan L, et al. Family aggregation of upper airway soft tissue structures in normal subjects and patients with sleep apnea. Am J Respir Crit Care Med. 2006;173:453–63.
67. Riha R, Diefenbach K, Jennum P, et al. Genetic aspects of hypertension and metabolic disease in the obstructive sleep apnoea–hypopnoea syndrome. Sleep Med Rev. 2008;12:49–63.
68. Pepperell J, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet. 2002;359:204–10.
69. Manolio T, Collins F, Cox N, et al. Finding the missing heritability of complex diseases. Nature. 2009;461:747–53.
70. Heard-Costa N, Zillikens M, Monda K, et al. NRXN3 is a novel locus for waist circumference: a genome-wide association study from the CHARGE Consortium. PLoS Genet. 2009;5:e1000539.
71. Heid I, Jackson A, Randall J, et al. Meta-analysis identifies 13 new loci associated with waist–hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet. 2010;42:949–60.
72. Lindgren C, Heid I, Randall J, et al. Genome-wide association scan meta-analysis identifies three loci influencing adiposity and fat distribution. PLoS Genet. 2009;5:e1000508.
73. Meyre D, Delplanque J, Chèvre J, et al. Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations. Nat Genet. 2009;41:157–59.
74. Scherag A, Dina C, Hinney A, et al. Two new loci for body-weight regulation identified in a joint analysis of genome-wide association studies for early-onset extreme obesity in French and German study groups. PLoS Genet. 2010;6:e1000916.
75. Thorleifsson G, Walters G, Gudbjartsson D, et al. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet. 2009;41:18–24.
76. Willer C, Speliotes E, Loos R, et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet. 2009;41:25–34.
77. Frayling T, Timpson N, Weedon M, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316:889–94.
78. Hinney A, Nguyen T, Scherag A, et al. Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants. PLoS ONE. 2007;2:e1361.
79. Scuteri A, Sanna S, Chen W, et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet. 2007;3:e115.
80. Chambers J, Elliott P, Zabaneh D, et al. Common genetic variation near MC4R is associated with waist circumference and insulin resistance. Nat Genet. 2008;40:716–18.
81. Loos R, Lindgren C, Li S, et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet. 2008;40:768–75.
82. Larkin EK, Patel SR, Redline S, et al. Apolipoprotein E and obstructive sleep apnea: evaluating whether a candidate gene explains a linkage peak. Genet Epidemiol. 2006;30:101–10.
83. Zhang J, Zhao B, Gesongluobu, et al. Angiotensin-converting enzyme gene insertion/deletion (I/D) polymorphism in hypertensive patients with different degrees of obstructive sleep apnea. Hypertens Res. 2000;23:407–11.
84. Lin L, Finn L, Zhang J, et al. Angiotensin-converting enzyme, sleep-disordered breathing, and hypertension. Am J Respir Crit Care Med. 2004;170:1349–53.
85. Li Y, Zhang W, Wang T, et al. Study on the polymorphism of angiotensin converting enzyme genes and serum angiotensin II level in patients with obstructive sleep apnea hypopnea syndrome accompanied hypertension. Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2004;18:456–59.
86. Patel S, Larkin E, Mignot E, et al. The association of angiotensin converting enzyme (ACE) polymorphisms with sleep apnea and hypertension. Sleep. 2007;30:531–33.
87. Boström K, Hedner J, Melander O. Interaction between the angiotensin-converting enzyme gene insertion/deletion polymorphism and obstructive sleep apnoea as a mechanism for hypertension. J Hypertens. 2007;25:779–83.
88. Koyama R, Drager L, Lorenzi-Filho G, et al. Reciprocal interactions of obstructive sleep apnea and hypertension associated with ACE I/D polymorphism in males. Sleep Med. 2009;10:1107–11.
89. Ogus C, Ket S, Bilgen T, et al. Insertion/deletion polymorphism and serum activity of the angiotensin-converting enzyme in Turkish patients with obstructive sleep apnea syndrome. Biochem Genet. 2010;48:516–23.
90. Bartels N, Börgel J, Wieczorek S. Risk factors and myocardial infarction in patients with obstructive sleep apnea: impact of beta2-adrenergic receptor polymorphisms. BMC Med. 2007;5:1–8.
91. Riha R, Brander P, Vennelle M. Tumour necrosis factor-alpha (-308) gene polymorphism in obstructive sleep apnoea–hypopnoea syndrome. Eur Respir J. 2005;26:673–78.
92. Bhushan B, Guleria R, Misra A, et al. TNF-alpha gene polymorphism and TNF-alpha levels in obese Asian Indians with obstructive sleep apnea. Respir Med. 2009;103:386–92.
93. Zhang X, Liu R, Lei Z, et al. Genetic variants in interleukin-6 modified risk of obstructive sleep apnea syndrome. Int J Mol Med. 2009;23:485–93.
94. Lavie L, Lotan R, Hochberg I, et al. Haptoglobin polymorphism is a risk factor for cardiovascular disease in patients with obstructive sleep apnea syndrome. Sleep. 2003;26:592–95.
95. Yue W, Liu H, Zhang J, et al. Association study of serotonin transporter gene polymorphisms with obstructive sleep apnea syndrome in Chinese Han population. Sleep. 2008;31:1535–41.
96. Diefenbach K, Kretschmer K, Bauer S. Endothelin-1 gene variant Lys198Asn and plasma endothelin level in obstructive sleep apnea. Cardiology. 2008;112:62–68.
97. Buck D, Diefenbach K, Penzel T, et al. Genetic polymorphisms in endothelin-receptor-subtype-a-gene as susceptibility factor for obstructive sleep apnea syndrome. Sleep Med. 2010;11:213–17.
98. Popko K, Gorska E, Wasik M. Frequency of distribution of leptin receptor gene polymorphism in obstructive sleep apnea patients. J Physiol Pharmacol. 2007;58:551–61.
99. Kadotani H, Kadotani T, Young T, et al. Association between apolipoprotein E epsilon4 and sleep-disordered breathing in adults. J Am Med Assoc. 2001;285:2888–90.
100. Gottlieb DJ, DeStefano AL, Foley DJ, et al. APOE epsilon4 is associated with obstructive sleep apnea/hypopnea: the Sleep Heart Health Study. Neurology. 2004;63:664–68.
101. Liu H, Liu K, Zhou Y, et al. Relationship between reduced nicotinamide adenine dinucleotide phosphate oxidase subunit p22phox gene polymorphism and obstructive sleep apnea–hypopnea syndrome in the Chinese Han population. Chin Med J (Engl). 2009;122:1369–74.
102. Yakut T, Karkucak M, Ursavas A, et al. Lack of association of ACE gene I/D polymorphism with obstructive sleep apnea syndrome in Turkish patients. Genet Mol Res. 2010;9:734–38.
103. Piérola J, Barceló A, de la Peña M. beta3-adrenergic receptor Trp64Arg polymorphism and increased body mass index in sleep apnoea. Eur Respir J. 2007;30:743–47.
104. Zhang L, Yao W, He Q, et al. Polymorphisms in the beta2 and beta3 adrenergic receptor genes in obstructive sleep apnea/hypopnea syndrome. Zhonghua Nei Ke Za Zhi. 2005;44:333–36.
105. Bayazit Y, Yilmaz M, Ciftci T. Association of the -1438G/A polymorphism of the 5-HT2A receptor gene with obstructive sleep apnea syndrome. ORL J Otorhinolaryngol Relat Spec. 2006;68:123–28.
106. Sakai K, Takada T, Nakayama H. Serotonin-2A and 2C receptor gene polymorphisms in Japanese patients with obstructive sleep apnea. Intern Med. 2005;44:928–33.
107. Ylmaz M, Bayazit Y, Ciftci T. Association of serotonin transporter gene polymorphism with obstructive sleep apnea syndrome. Laryngoscope. 2005;115:832–36.
108. Bayazit Y, Yilmaz M, Kokturk O. Association of GABA(B)R1 receptor gene polymorphism with obstructive sleep apnea syndrome. ORL J Otorhinolaryngol Relat Spec. 2007;69:190–97.
109. Hanaoka M, Yu X, Urushihata K, et al. Leptin and leptin receptor gene polymorphisms in obstructive sleep apnea syndrome. Chest. 2008;133:79–85.
110. Barcelo A, Llompart E, Barbe F, et al. Plasminogen activator inhibitor-I (PAI-I) polymorphisms in patients with obstructive sleep apnoea. Respir Med. 2002;96:193–96.
111. Saarelainen S, Lehtimaki T, Kallonen E, et al. No relation between apolipoprotein E alleles and obstructive sleep apnea. Clin Genet. 1998;53:147–48.
112. Foley DJ, Masaki K, White L, et al. Relationship between apolipoprotein E epsilon4 and sleep-disordered breathing at different ages. J Am Med Assoc. 2001;286:1447–48.
113. Sánchez-de-la-Torre M, Pierola J, Vidal C, et al. Non-synonymous polymorphism in the neuropeptide S precursor gene and sleep apnea. Sleep Breath. 2011;15:403–08.
114. Schunkert H, König I, Kathiresan S, et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet. 2011;43:333–38.
115. Coronary Artery Disease (C4D) Genetics Consortium. A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat Genet. 2011;43:339–44.
116. Reilly M, Li M, He J, et al. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet. 2011;377:383–92.
117. Levy D, Ehret G, Rice K, et al. Genome-wide association study of blood pressure and hypertension. Nat Genet. 2009;41:677–87.
118. Newton-Cheh C, Johnson T, Gateva V, et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet. 2009;41:666–76.
119. Wellcome Trust Case Consortium. Genome-wide association study of 14,000 cases of seven diseases and 3,000 shared controls. Nature. 2007;447:661–78.
120. Zeggini E, Scott L, Saxena R, et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet. 2008;40:638–45.
121. Voight B, Scott L, Steinthorsdottir V, et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 2010;42:579–89.
122. Salonen J, Uimari P, Aalto J, et al. Type 2 diabetes whole-genome association study in four populations: the DiaGen consortium. Am J Hum Genet. 2007;81:338–45.
123. Qi L, Cornelis M, Kraft P, et al. Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes. Hum Mol Genet. 2010;19:2706–15.
124. Scott L, Mohlke K, Bonnycastle L, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007;316:1341–45.
125. Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University and Novartis Institutes of BioMedical Research, Saxena R, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 2007;316:1331–36.
126. Zeggini E, Weedon M, Lindgren C, et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science. 2007;316:1336–41.
127. Takeuchi F, Serizawa M, Yamamoto K, et al. Confirmation of multiple risk loci and genetic impacts by a genome-wide association study of type 2 diabetes in the Japanese population. Diabetes. 2009;58:1690–99.
128. Unoki H, Takahashi A, Kawaguchi T, et al. SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat Genet. 2008;40:1098–102.
129. Rung J, Cauchi S, Albrechtsen A, et al. Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat Genet. 2009;41:1110–15.
130. Timpson N, Lindgren C, Weedon M, et al. Adiposity-related heterogeneity in patterns of type 2 diabetes susceptibility observed in genome-wide association data. Diabetes. 2009;58:505–10.
131. Steinthorsdottir V, Thorleifsson G, Reynisdottir I, et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet. 2007;39:770–75.
132. Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007;445:881–85.
133. Shu X, Long J, Cai Q, et al. Identification of new genetic risk variants for type 2 diabetes. PLoS Genet. 2010;6:e1001127.
134. Yasuda K, Miyake K, Horikawa Y, et al. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet. 2008;40:1092–97.
135. Yamauchi T, Hara K, Maeda S, et al. A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A–C2CD4B. Nat Genet. 2010;42:864–68.
136. Erdmann J, Willenborg C, Nahrstaedt J, et al. Genome-wide association study identifies a new locus for coronary artery disease on chromosome 10p11.23. Eur Heart J. 2011;32(2):158–68.